Oncoxin-Viusid(®) may improve quality of life and survival in patients with hormone-refractory prostate cancer undergoing onco-specific treatments

por Fundora Ramos, Mercedes Iveet, Maden, Lourdes Boulet, Casanova, Fernando Oriol, Cruz, Frank Hernández, Reyes, Carina Salgado, Gato, Adalberto Hernandez, Lyncon, Israel Benítez, González, Etna Vega, Morales, Katia Palau, Lence, Juan J., Sanz, Eduardo
Publicado 2021